References
- Duley L. Preeclampsia and the hypertensive disorders of pregnancy. Br Med Bull 2003;67:161–176.
- Idama TO, Lindow SW. Magnesium sulfate: a review of clinical pharmacology applied to obstetrics. Br J Obstet Gynecol 1998;105:260.
- Kynclzl Leisure M, Cibils LA. Increased bleeding time after magnesium sulfate infusion. Am J Obstet Gynecol 1996;175:1293–1294.
- Schroeder BM. American College of Obstetricians and Gynecologists (ACOG) practice bulletin on diagnosing and managing preeclampsia and eclampsia. Am Fam Physician 2002;66:330–331.
- Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Ann 1972;1:177–191.
- Ferrara N. Role of VEGF in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 2001;280:1358–1366.
- Harnett MJP, Datta S, Bhavani-Shankar K. The effect of magnesium on coagulation in parturients with preeclampsia. Anesth Analg 2001;92:1257–1260.
- Irminger-Finger I, Jastrow N, Irion O. Preeclampsia: a danger growing in disguise. Int J Biochem Cell Biol 2008;10:1016.
- Ballegeer VC, Spitz B, Baene LA. Platelet activation in vasculer damage in gestational hipertansion. Am J Obstet Gynecol 1992;166:629–633.
- Giles C. The platelet count and mean platelet volume. Br J Haematol 1981;48:31–37.
- Thornton CA, Bonnar J. Factor VIII-related antigen and factor VIII coagulant activity in normal and preeclamptic pregnancy. Br J Obstet Gynaecol 1977;84:919–923.
- de Boer K, ten Cate JW, Sturk A, Borm J, Treffers PE. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol 1989;160:95–100.
- Grisaru D, Zwang E, Peyser MR, Lessing JB, Eldor A. The procoagulant activity of red blood cells from patients with severe preeclampsia. Am J Obstet Gynecol 1997;177:1513–1516.
- Fuentes A, Rojas A, Porter KB, et al The effect of magnesium sulfate on bleeding time in pregnancy. Am J Obstet Gynecol 1995;173:1246–1249.
- Serebruany VL, Herzog WR, Schlossberg ML, Gurbel PA. Bolus magnesium infusion in humans is associated with predominantly unfavourable changes in platelet aggregation and certain haemostatic factors. Pharmacol Res 1997;36:17–22.
- Assaley J, Baron JM, Cibils LA. Effects of magnesium sulfate infusion upon clotting parameters in patients with pre-eclampsia. J Perinat Med 1998;26:115–119.
- Ravn HB, Vissinger H, Kristensen SD, Husted SE. Magnesium inhibits platelet activity: an in vitro study. Thromb Haemost 1996;76:88–93.
- James MFM, Neil G. Effect of magnesium on coagulation as measured by thrombelastography. Br J Anesth 1995;74:92–94.
- Cott EMV, Laposata M. Coagulation. In: Jacobs DS, Oxley DK, Demott WR editors. The Laboratory Test Handbook, 5th ed. Cleveland: Lexi-Comp; 2001. pp 327–358.
- Essell JH, Martin TJ, Salinas J, Thompson JM, Smith VC. Comparison of thrombelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1993;7:410–415.
- Malett SV, Cox DJA. Thrombelastograhy. Br J Anaesth 1992;69:307–313.
- Moghadas FRS, Motevalıan M, Rezai Z, Ehteshamipour E. The effect of magnesium sulfate therapy on bleeding time in women with threatened preterm labor. IJPT 2007;6:55–57.
- Holcberg G, Sapir O, Hallak M, Sheiner E, Ducler D, Katz M, Huleihel M. Selective vasodilator effect of magnesium sulfate in human placenta. Am J Reprod Immunol 2004;51:192–197.